Search

Author/Creator Jiang, Peter

2. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. Issue 7 (July 2021)

Authors:
Powles, Thomas; Csőszi, Tibor; Özgüroğlu, Mustafa; Matsubara, Nobuaki; Géczi, Lajos; Cheng, Susanna Y-S; Fradet, Yves; Oudard, Stephane; Vulsteke, Christof; Morales Barrera, Rafael; Fléchon, Aude; Gunduz, Seyda; Loriot, Yohann; Rodriguez-Vida, Alejo; Mamtani, Ronac; Yu, Evan Y; Nam, Kijoeng; Imai...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 7(2021)
Page Start:
931
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 9 (September 2022)

Authors:
Powles, Thomas; Tomczak, Piotr; Park, Se Hoon; Venugopal, Balaji; Ferguson, Thomas; Symeonides, Stefan N; Hajek, Jaroslav; Gurney, Howard; Chang, Yen-Hwa; Lee, Jae Lyun; Sarwar, Naveed; Thiery-Vuillemin, Antoine; Gross-Goupil, Marine; Mahave, Mauricio; Haas, Naomi B; Sawrycki, Piotr; Burgents, Jo...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 9(2022)
Page Start:
1133
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients. Issue 2 (29th January 2019)

Authors:
Rivkin, Saul Eugene; Moon, James; Iriarte, Desiree S; Bailey, Erik; Sloan, Heather L; Goodman, Gary E; BonDurant, Amy E; Velijovich, Dan; Wahl, Tanya; Jiang, Peter; Shah, Chirag A; Drescher, Charles; Fer, Mehmet F; Kaplan, Henry G; Ellis, Erin D
Journal:
International journal of gynecological cancer
Issue:
Volume 29:Issue 2(2019)
Page Start:
325
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients. Issue 2 (February 2019)

Authors:
Rivkin, Saul Eugene; Moon, James; Iriarte, Desiree S; Bailey, Erik; Sloan, Heather L; Goodman, Gary E; BonDurant, Amy E; Velijovich, Dan; Wahl, Tanya; Jiang, Peter; Shah, Chirag A; Drescher, Charles; Fer, Mehmet F; Kaplan, Henry G; Ellis, Erin D
Journal:
International journal of gynecological cancer
Issue:
Volume 29:Issue 2(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. S27 Impact of an Exocrine Pancreatic Insufficiency Order Set on Adequacy of Management of Exocrine Pancreatic Insufficiency and Related Complications. (October 2022)

Authors:
Madhok, Ishaan; Bhat, Adnan; Ruiz, Nicole; Brown, Jackson; Wilson, Jake; Jiang, Peter; Radetic, Mark; Taylor, Robert; George, John; Forsmark, Christopher
Other Names:
Ladna Michael presenter.
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10S
Page Start:
e21
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗